{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:23:07Z","timestamp":1783974187690,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1124\/jpet.114.220970","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T02:52:34Z","timestamp":1425523954000},"page":"330-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Beneficial Effect of the Soluble Guanylyl Cyclase Stimulator BAY 41-2272 on Impaired Penile Erection in db\/db\u2212\/\u2212 Type II Diabetic and Obese Mice"],"prefix":"10.1016","volume":"353","author":[{"given":"Kenia Pedrosa","family":"Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleber E.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda B.M.","family":"Priviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroldo A.","family":"Toque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Clinton","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.220970_bib1","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI115260","article-title":"Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans","volume":"87","author":"Anderson","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.220970_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/pr.111.004515","article-title":"Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction","volume":"63","author":"Andersson","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.114.220970_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1743-6109.2009.01587.x","article-title":"Diabetes exacerbates the functional deficiency of NO\/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries","volume":"7","author":"Angulo","year":"2010","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.114.220970_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1743-6109.2008.01088.x","article-title":"The novel antioxidant, AC3056 (2,6-di-t-butyl-4-((dimethyl-4-methoxyphenylsilyl)methyloxy)phenol), reverses erectile dysfunction in diabetic rats and improves NO-mediated responses in penile tissue from diabetic men","volume":"6","author":"Angulo","year":"2009","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.114.220970_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-5347(06)00589-1","article-title":"A prospective study of risk factors for erectile dysfunction","volume":"176","author":"Bacon","year":"2006","journal-title":"J Urol"},{"key":"10.1124\/jpet.114.220970_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2003.08.012","article-title":"Relaxing effects induced by the soluble guanylyl cyclase stimulator BAY 41-2272 in human and rabbit corpus cavernosum","volume":"477","author":"Baracat","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.114.220970_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2210-1-13","article-title":"NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272","volume":"1","author":"Becker","year":"2001","journal-title":"BMC Pharmacol"},{"key":"10.1124\/jpet.114.220970_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0090-4295(02)02121-0","article-title":"BAY 41-2272: a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo","volume":"61","author":"Bischoff","year":"2003","journal-title":"Urology"},{"key":"10.1124\/jpet.114.220970_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1517\/14728222.10.3.445","article-title":"Nitric oxide\/redox-based signalling as a therapeutic target for penile disorders","volume":"10","author":"Burnett","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.1124\/jpet.114.220970_bib10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1743-6109.2007.00752.x","article-title":"Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db\/db mouse","volume":"5","author":"Carneiro","year":"2008","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.114.220970_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1056-8719(02)00204-6","article-title":"Characterization of the rat isolated retractor penis muscle as a model for the study of nitrergic transmission","volume":"47","author":"Cheah","year":"2002","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"Suppl 3","key":"10.1124\/jpet.114.220970_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1743-6109.2008.01183.x","article-title":"Type 1 and Type 2 diabetic-erectile dysfunction: same diagnosis (ICD-9), different disease?","volume":"6","author":"Chitaley","year":"2009","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.114.220970_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11892-002-0059-5","article-title":"Erectile dysfunction and diabetes","volume":"2","author":"Chu","year":"2002","journal-title":"Curr Diab Rep"},{"key":"10.1124\/jpet.114.220970_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1464-410X.2010.09776.x","article-title":"Long-term oral treatment with BAY 41-2272 ameliorates impaired corpus cavernosum relaxations in a nitric oxide-deficient rat model","volume":"108","author":"Claudino","year":"2011","journal-title":"BJU Int"},{"key":"10.1124\/jpet.114.220970_bib15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.urology.2009.05.098","article-title":"Upregulation of gp91phox subunit of NAD(P)H oxidase contributes to erectile dysfunction caused by long-term nitric oxide inhibition in rats: reversion by regular physical training","volume":"75","author":"Claudino","year":"2010","journal-title":"Urology"},{"key":"10.1124\/jpet.114.220970_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.114.220970_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1100\/tsw.2009.79","article-title":"Obesity and erectile dysfunction: is androgen deficiency the common link?","volume":"9","author":"Feeley","year":"2009","journal-title":"ScientificWorldJournal"},{"key":"10.1124\/jpet.114.220970_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ijir.2010.1","article-title":"Determinants of erectile dysfunction in type 2 diabetes","volume":"22","author":"Giugliano","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1124\/jpet.114.220970_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1743-6109.2009.01624.x","article-title":"Anatomy, physiology, and pathophysiology of erectile dysfunction","volume":"7","author":"Gratzke","year":"2010","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.114.220970_bib20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase: role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ Res"},{"key":"10.1124\/jpet.114.220970_bib21","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/01.CIR.0000012748.58444.08","article-title":"Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase","volume":"105","author":"Guzik","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/jpet.114.220970_bib22","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1743-6109.2008.01116.x","article-title":"Review type 2 diabetes mellitus and erectile dysfunction","volume":"6","author":"Hidalgo-Tamola","year":"2009","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.114.220970_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/postgradmedj-2011-130069","article-title":"Sexual dysfunction in men with type 2 diabetes","volume":"88","author":"Isidro","year":"2012","journal-title":"Postgrad Med J"},{"key":"10.1124\/jpet.114.220970_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1745-7262.2008.00371.x","article-title":"NADPH oxidase: recent evidence for its role in erectile dysfunction","volume":"10","author":"Jin","year":"2008","journal-title":"Asian J Androl"},{"key":"10.1124\/jpet.114.220970_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1743-6109.2007.00733.x","article-title":"NADPH oxidase activation: a mechanism of hypertension-associated erectile dysfunction","volume":"5","author":"Jin","year":"2008","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.114.220970_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.ijir.3901224","article-title":"A comparative study of sildenafil, NCX-911 and BAY41-2272 on the anococcygeus muscle of diabetic rats","volume":"16","author":"Kalsi","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1124\/jpet.114.220970_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-5347(05)64009-8","article-title":"BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro","volume":"169","author":"Kalsi","year":"2003","journal-title":"J Urol"},{"key":"10.1124\/jpet.114.220970_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1464-410X.2005.05643.x","article-title":"Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells","volume":"96","author":"Koupparis","year":"2005","journal-title":"BJU Int"},{"key":"10.1124\/jpet.114.220970_bib29","first-page":"2010","article-title":"A review of the pathophysiology and novel treatments for erectile dysfunction","volume":"2010","author":"Lasker","year":"2010","journal-title":"Adv Pharmacol Sci"},{"key":"10.1124\/jpet.114.220970_bib30","first-page":"262","article-title":"Modulation of soluble guanylate cyclase for the treatment of erectile dysfunction","volume":"28","author":"Lasker","year":"2013","journal-title":"Physiology (Bethesda)"},{"key":"10.1124\/jpet.114.220970_bib31","doi-asserted-by":"crossref","first-page":"R277","DOI":"10.1152\/ajpregu.00758.2002","article-title":"Vascular NAD(P)H oxidases: specific features, expression, and regulation","volume":"285","author":"Lass\u00e8gue","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.114.220970_bib32","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2164\/jandrol.112.016642","article-title":"NADPH oxidase activation: a mechanism of erectile dysfunction in a rat model of sleep apnea","volume":"33","author":"Liu","year":"2012","journal-title":"J Androl"},{"key":"10.1124\/jpet.114.220970_bib33","doi-asserted-by":"crossref","first-page":"H2204","DOI":"10.1152\/ajpheart.00027.2008","article-title":"Erectile dysfunction in the type II diabetic db\/db mouse: impaired venoocclusion with altered cavernosal vasoreactivity and matrix","volume":"294","author":"Luttrell","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.114.220970_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bmj.332.7541.589","article-title":"Treating erectile dysfunction when PDE5 inhibitors fail","volume":"332","author":"McMahon","year":"2006","journal-title":"BMJ"},{"key":"10.1124\/jpet.114.220970_bib35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1745-7262.2006.00223.x","article-title":"Pathophysiology and treatment of diabetic erectile dysfunction","volume":"8","author":"Moore","year":"2006","journal-title":"Asian J Androl"},{"key":"10.1124\/jpet.114.220970_bib36","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1111\/j.1743-6109.2011.02499.x","article-title":"Extracellular signal-regulated kinase (ERK) inhibition decreases arginase activity and improves corpora cavernosal relaxation in streptozotocin (STZ)-induced diabetic mice","volume":"8","author":"Nunes","year":"2011","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.114.220970_bib37","series-title":"Erectile Dysfunction: Disease-Associated Mechanisms and Novel Insights into Therapy","first-page":"3","article-title":"Mechanisms in erectile function and dysfunction: an overview","author":"Nunes","year":"2012"},{"key":"10.1124\/jpet.114.220970_bib38","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1440-1681.2005.04262.x","article-title":"Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator","volume":"32","author":"Priviero","year":"2005","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.114.220970_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1464-410X.2008.07911.x","article-title":"The administration of folic acid improves erectile function and reduces intracavernosal oxidative stress in the diabetic rabbit","volume":"103","author":"Shukla","year":"2009","journal-title":"BJU Int"},{"key":"10.1124\/jpet.114.220970_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejphar.2005.05.012","article-title":"Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits","volume":"517","author":"Shukla","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.114.220970_bib41","doi-asserted-by":"crossref","first-page":"H1393","DOI":"10.1152\/ajpheart.00708.2013","article-title":"Oxidative stress associated with middle aging leads to sympathetic hyperactivity and downregulation of soluble guanylyl cyclase in corpus cavernosum","volume":"307","author":"Silva","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.114.220970_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35065611","article-title":"NO-independent regulatory site on soluble guanylate cyclase","volume":"410","author":"Stasch","year":"2001","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1124\/jpet.114.220970_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.genm.2008.12.003","article-title":"Diabetes, obesity, and erectile dysfunction","volume":"6","author":"Tamler","year":"2009","journal-title":"Gend Med"},{"key":"10.1124\/jpet.114.220970_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2005.11.015","article-title":"Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: interaction with nitric oxide","volume":"530","author":"Teixeira","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.114.220970_bib45","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.HYP.0000199914.36936.1b","article-title":"Vasorelaxing effect of BAY 41-2272 in rat basilar artery: involvement of cGMP-dependent and independent mechanisms","volume":"47","author":"Teixeira","year":"2006","journal-title":"Hypertension"},{"key":"10.1124\/jpet.114.220970_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1124\/jpet.105.095752","volume":"317","author":"Teixeira","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.220970_bib47","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1124\/jpet.107.124594","volume":"322","author":"Teixeira","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.220970_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pharmthera.2004.11.011","article-title":"Nitric oxide and penile erectile function","volume":"106","author":"Toda","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.114.220970_bib49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.urology.2007.12.031","article-title":"Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra","volume":"72","author":"Toque","year":"2008","journal-title":"Urology"},{"key":"10.1124\/jpet.114.220970_bib50","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/jsm.12134","article-title":"Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation","volume":"10","author":"Toque","year":"2013","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.114.220970_bib51","doi-asserted-by":"crossref","first-page":"e72277","DOI":"10.1371\/journal.pone.0072277","article-title":"Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function","volume":"8","author":"Toque","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.114.220970_bib52","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1743-6109.2010.02098.x","article-title":"Arginase II deletion increases corpora cavernosa relaxation in diabetic mice","volume":"8","author":"Toque","year":"2011","journal-title":"J Sex Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652419012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652419012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.220970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:59:25Z","timestamp":1739987965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652419012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S002235652419012X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.220970","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial Effect of the Soluble Guanylyl Cyclase Stimulator BAY 41-2272 on Impaired Penile Erection in db\/db\u2212\/\u2212 Type II Diabetic and Obese Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.220970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}